Testing of new combination drug approved by KFDA

Published: 2012-09-03 06:57:00

Updated: 2012-09-03 06:57:00

Ildong Pharmaceutical said Wednesday it has received approval from the Korea Food and Drug Administration to conduct clinical trials of a combination drug for the treatment of hypertension and hyperlipidemia.

The drug is a single-pill combination of telmisartan and rosuvastatin.

“The new co...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK